CVS compared with GRDN: revenue, margins and what each company keeps, and the suppliers and customers both name

CVSCVS Health Corp

Mkt capRevenueRevenue

GRDNGuardian Pharmacy Services, Inc.

Mkt capRevenueRevenue

Compare

CVSCVS Health Corp

GRDNGuardian Pharmacy Services, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

CVS

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.9%▼−12.53%×2.12

Q2 FY26±4.9%▼−5.08%×1.04

Q1 FY26±5.7%▲+7.65%×1.35

Feb 10 '26±5.3%▼−0.09%×0.02

GRDN

1 of 3at or beyond implied

Reportimpliedrealized× implied

Q3 FY26—▲+6.32%—

Q2 FY26±11.1%▲+11.05%×1.00

= impliedCVS realized, solidGRDN realized, hatchedOne scale, both sides: full bar = 14%× = |realized| ÷ impliedSource: market data

May 7 '26

±10.9%

▼−0.85%

×0.07

Q1 FY26±13.6%▼−0.72%×0.05

CVSCVS Health Corp

85.18▲+1.59%

Mkt cap$107.3BRevenue$108BQ3 FY26Revenue$402BFY25

GRDNGuardian Pharmacy Services, Inc.

44.65▲+5.34%

Regular sessionNov 9 '26

Mkt cap$2.7BRevenue$371MQ3 FY26Revenue$1.4BFY25

Compare

Regular sessionNov 9 '26

CVSCVS Health Corp

GRDNGuardian Pharmacy Services, Inc.

85.18▲+1.59%

Price

44.65▲+5.34%

$107.3B

Mkt cap

$2.7B

Q3 FY26$108B

Revenue

$371MQ3 FY26

FY25$402B

Revenue

$1.4BFY25

CVS85.18▲+1.59%vsGRDN44.65▲+5.34%Regular sessionNov 9 '26